| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.12.24 | Entersoft-Softone Merger: A leader in Business Software | ||
| 29.10.24 | ENTERSOFT: New acquisition and the battle with Viva | ||
| 11.10.24 | Viva's injunctions against SoftOne-Entersoft rejected | ||
| 02.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Matinas BioPharma Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | ||
| 11.03. | Matinas BioPharma Holdings, Inc.: Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors | ||
| 11.03. | Matinas BioPharma Holdings, Inc. - 8-K, Current Report | ||
| 13.02. | Matinas BioPharma announces agreement for the acquisition of preferred stock | ||
| 13.02. | Matinas BioPharma Holdings, Inc.: Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.11.24 | Mattioli Woods: Profit slashed at wealth manager as it quit London | ||
| 02.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen | |
| 02.09.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024 | Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.03. | Oruka Therapeutics zeigt Fortschritte trotz Verlusten | ||
| 07.03. | Stifel maintains Buy rating on Oruka Therapeutics stock, $49 target | ||
| 07.03. | Oruka Therapeutics, Inc.: Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting | Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of two to three times per year Equivalent potency to bimekizumab... ► Artikel lesen | |
| 06.03. | Oruka Therapeutics, Inc. Q4 Loss Narrows | ||
| 06.03. | ARCA biopharma GAAP EPS of -$0.49 misses by $0.08 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC | Leuven, BELGIUM - March 27, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| Do | OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC | Leuven, BELGIUM - March 27, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| 24.03. | OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital... ► Artikel lesen | |
| 18.03. | OXURION: Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO | Louvain, BELGIUM - March 18, 2025 - 6:30 PM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the signing of a letter of intent (LOI) for... ► Artikel lesen | |
| 18.03. | OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC | Leuven, BELGIUM - March 18, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ADVANTAGEWON OIL CORP | - | - |
| ENTERSOFT SA | 7,920 | 0,00 % |
| MATINAS BIOPHARMA HOLDINGS INC | 0,054 | 0,00 % |
| MATTIOLI WOODS PLC | 9,250 | 0,00 % |
| ORUKA THERAPEUTICS INC | 11,200 | +26,55 % |
| OXURION NV | 0,100 | 0,00 % |
